Fulcrum Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of FULC for the last quarter is 871.00 k USD, and it's 14.76% higher compared to the previous quarter. The net income of Q4 23 is -24.76 M USD.